Literature DB >> 30963990

Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis.

Francesca Tamarozzi1, Elisa Martello2, Giovanni Giorli1, Andrea Fittipaldo3, Silvia Staffolani4, Antonio Montresor5, Zeno Bisoffi6,1, Dora Buonfrate1.   

Abstract

Strongyloides stercoralis, a worldwide-distributed soil-transmitted helminth, causes chronic infection which may be life threatening. Limitations of diagnostic tests and nonspecificity of symptoms have hampered the estimation of the global morbidity due to strongyloidiasis. This work aimed at assessing S. stercoralis-associated morbidity through a systematic review and meta-analysis of the available literature. MEDLINE, Embase, CENTRAL, LILACS, and trial registries (WHO portal) were searched. The study quality was assessed using the Newcastle-Ottawa scale. Odds ratios (ORs) of the association between symptoms and infection status and frequency of infection-associated symptoms were calculated. Six articles from five countries, including 6,014 individuals, were included in the meta-analysis-three were of low quality, one of high quality, and two of very high quality. Abdominal pain (OR 1.74 [CI 1.07-2.94]), diarrhea (OR 1.66 [CI 1.09-2.55]), and urticaria (OR 1.73 [CI 1.22-2.44]) were associated with infection. In 17 eligible studies, these symptoms were reported by a large proportion of the individuals with strongyloidiasis-abdominal pain by 53.1% individuals, diarrhea by 41.6%, and urticaria by 27.8%. After removing the low-quality studies, urticaria remained the only symptom significantly associated with S. stercoralis infection (OR 1.42 [CI 1.24-1.61]). Limitations of evidence included the low number and quality of studies. Our findings especially highlight the appalling knowledge gap about clinical manifestations of this common yet neglected soil-transmitted helminthiasis. Further studies focusing on morbidity and risk factors for dissemination and mortality due to strongyloidiasis are absolutely needed to quantify the burden of S. stercoralis infection and inform public health policies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30963990      PMCID: PMC6553888          DOI: 10.4269/ajtmh.18-0895

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  [New trial with thiabendazole for treatment of human strongyloidiasis].

Authors:  T Oyakawa; T Kuniyoshi; T Arakaki; A Higashionna; K Shikiya; H Sakugawa; K Kadena; K Kitsukawa; F Kinjo; A Saito
Journal:  Kansenshogaku Zasshi       Date:  1991-03

2.  [Clinical study on ivermectin against Strongyloides stercoralis].

Authors:  K Shikiya; T Uehara; H Uechi; J Ohshiro; T Arakaki; T Oyakawa; H Sakugawa; F Kinjo; A Saito; R Asato
Journal:  Kansenshogaku Zasshi       Date:  1991-09

3.  [Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru].

Authors:  Luis Marcos; Angélica Terashima; Frine Samalvides; Héctor Alvarez; Felipe Lindo; Raúl Tello; Marco Canales; Julio Demarini; Eduardo Gotuzzo
Journal:  Rev Gastroenterol Peru       Date:  2005 Oct-Dec

4.  Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart.

Authors:  Osamu Zaha; Tetsuo Hirata; Fukunori Kinjo; Atsushi Saito; Hiroshi Fukuhara
Journal:  J Infect Chemother       Date:  2002-03       Impact factor: 2.211

5.  Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness.

Authors:  D I Grove
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

Review 6.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

7.  Prevalence and risk factors of Strongyloides stercoralis in Takeo Province, Cambodia.

Authors:  Virak Khieu; Fabian Schär; Hanspeter Marti; Philipp J Bless; Meng Chuor Char; Sinuon Muth; Peter Odermatt
Journal:  Parasit Vectors       Date:  2014-05-12       Impact factor: 3.876

Review 8.  Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection-A systematic review and meta-analysis.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Michela Cinquini; Mario Cruciani; Andrea Fittipaldo; Giovanni Giorli; Federico Gobbi; Chiara Piubelli; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2018-02-09

Review 9.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

10.  Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children.

Authors:  Armelle Forrer; Virak Khieu; Fabian Schär; Jan Hattendorf; Hanspeter Marti; Andreas Neumayr; Meng Chuor Char; Christoph Hatz; Sinuon Muth; Peter Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2017-10-23
View more
  14 in total

1.  The neural basis of heat seeking in a human-infective parasitic worm.

Authors:  Astra S Bryant; Felicitas Ruiz; Joon Ha Lee; Elissa A Hallem
Journal:  Curr Biol       Date:  2022-04-27       Impact factor: 10.900

2.  [28/f-Migrant from Nigeria with eosinophilia, abdominal complaints and anemia : Preparation for the medical specialist examination: part 80].

Authors:  A Niederfahrenhorst; C Rothe
Journal:  Internist (Berl)       Date:  2021-08-26       Impact factor: 0.743

Review 3.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

4.  Mapping the Prevalence of Strongyloides stercoralis Infection in Ecuador: A Serosurvey.

Authors:  Angel Gustavo Guevara; Mariella Anselmi; Zeno Bisoffi; Rosanna Prandi; Monica Márquez; Ronaldo Silva; Yosselin Vicuña; Manuel Calvopiña; William Cevallos; Jorge Pérez; Lucy Baldeón; Dora Buonfrate
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

5.  Strongyloides stercoralis infection in San Marino Republic: first epidemiological data from an observational study.

Authors:  E D Cappella; A C Piscaglia; A Cadioli; S Manoni; R Silva; D Buonfrate
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Advances in the Molecular and Cellular Biology of Strongyloides spp.

Authors:  Tegegn G Jaleta; James B Lok
Journal:  Curr Trop Med Rep       Date:  2019-09-13

7.  Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union.

Authors:  Philip Erick Wikman-Jorgensen; Jara Llenas-Garcia; Jad Shedrawy; Joaquim Gascon; Jose Muñoz; Zeno Bisoffi; Ana Requena-Mendez
Journal:  BMJ Glob Health       Date:  2020-05

8.  The Global Prevalence of Strongyloides stercoralis Infection.

Authors:  Dora Buonfrate; Donal Bisanzio; Giovanni Giorli; Peter Odermatt; Thomas Fürst; Christina Greenaway; Michael French; Richard Reithinger; Federico Gobbi; Antonio Montresor; Zeno Bisoffi
Journal:  Pathogens       Date:  2020-06-13

9.  The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030.

Authors:  Antonio Montresor; Denise Mupfasoni; Alexei Mikhailov; Pauline Mwinzi; Ana Lucianez; Mohamed Jamsheed; Elkan Gasimov; Supriya Warusavithana; Aya Yajima; Zeno Bisoffi; Dora Buonfrate; Peter Steinmann; Jürg Utzinger; Bruno Levecke; Johnny Vlaminck; Piet Cools; Jozef Vercruysse; Giuseppe Cringoli; Laura Rinaldi; Brittany Blouin; Theresa W Gyorkos
Journal:  PLoS Negl Trop Dis       Date:  2020-08-10

10.  High Prevalence of Strongyloides among South Asian Migrants in Primary Care-Associations with Eosinophilia and Gastrointestinal Symptoms.

Authors:  Elinor Chloe Baker; Damien K Ming; Yasmin Choudhury; Shahedur Rahman; Philip J Smith; Jose Muñoz; Peter L Chiodini; Chris J Griffiths; Christopher Jm Whitty; Michael Brown
Journal:  Pathogens       Date:  2020-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.